Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06791005Phase 3Recruiting
A Phase 3 trial of carbon nanoparticles in papillary thyroid cancer (PTC), sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Started Jan 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06791005.